In Vitro Screening Test Using Leishmania Promastigotes Stably Expressing mCherry Protein

ABSTRACT Transgenic Leishmania major and Leishmania donovani axenic promastigotes constitutively expressing mCherry were used for in vitro antileishmanial drug screening. This method requires minimal sample manipulation and can be easily adapted to automatic drug tests, allowing primary high-throughput screenings without the need for expensive and sophisticated instruments.

[1]  S. Beverley,et al.  An alternative in vitro drug screening test using Leishmania amazonensis transfected with red fluorescent protein. , 2013, Diagnostic microbiology and infectious disease.

[2]  R. Madhubala,et al.  Visceral and post-Kala-Azar dermal leishmaniasis isolates show significant difference in their in vitro drug susceptibility pattern , 2013, Parasitology Research.

[3]  S. Castanys,et al.  Leishmania donovani Develops Resistance to Drug Combinations , 2012, PLoS neglected tropical diseases.

[4]  Y. Pérez-Pertejo,et al.  Appraisal of a Leishmania major Strain Stably Expressing mCherry Fluorescent Protein for Both In Vitro and In Vivo Studies of Potential Drugs and Vaccine against Cutaneous Leishmaniasis , 2012, PLoS neglected tropical diseases.

[5]  J. Le bras,et al.  Leishmania Resistance to Miltefosine Associated with Genetic Marker , 2012, Emerging infectious diseases.

[6]  P. Leprohon,et al.  Multiple Mutations in Heterogeneous Miltefosine-Resistant Leishmania major Population as Determined by Whole Genome Sequencing , 2012, PLoS neglected tropical diseases.

[7]  A. Bolhassani,et al.  Fluorescent Leishmania species: development of stable GFP expression and its application for in vitro and in vivo studies. , 2011, Experimental parasitology.

[8]  M. Wilson,et al.  Leukocytes Infiltrate the Skin and Draining Lymph Nodes in Response to the Protozoan Leishmania infantum chagasi , 2010, Infection and Immunity.

[9]  S. Sundar,et al.  Drug Resistance in Leishmaniasis , 2010, Journal of global infectious diseases.

[10]  Verena M C Quent,et al.  Discrepancies between metabolic activity and DNA content as tool to assess cell proliferation in cancer research , 2010, Journal of cellular and molecular medicine.

[11]  Taosheng Chen,et al.  A Practical Guide to Assay Development and High-Throughput Screening in Drug Discovery , 2009 .

[12]  P. Pescher,et al.  Leishmania major MPK7 Protein Kinase Activity Inhibits Intracellular Growth of the Pathogenic Amastigote Stage , 2009, Eukaryotic Cell.

[13]  V. Avery,et al.  Development of an Alamar Blue viability assay in 384-well format for high throughput whole cell screening of Trypanosoma brucei brucei bloodstream form strain 427. , 2009, The American journal of tropical medicine and hygiene.

[14]  Nasib Singh,et al.  Reporter genes facilitating discovery of drugs targeting protozoan parasites. , 2009, Trends in parasitology.

[15]  Dhiraj Kumar,et al.  In Vitro Susceptibility of Field Isolates of Leishmania donovani to Miltefosine and Amphotericin B: Correlation with Sodium Antimony Gluconate Susceptibility and Implications for Treatment in Areas of Endemicity , 2008, Antimicrobial Agents and Chemotherapy.

[16]  R. Schooley,et al.  Real-Time In Vivo Green Fluorescent Protein Imaging of a Murine Leishmaniasis Model as a New Tool for Leishmania Vaccine and Drug Discovery , 2008, Clinical and Vaccine Immunology.

[17]  R. López-Vélez,et al.  The Relationship between Leishmaniasis and AIDS: the Second 10 Years , 2008, Clinical Microbiology Reviews.

[18]  A. Gómez-Barrio,et al.  Development of resazurin microtiter assay for drug sensibility testing of Trypanosoma cruzi epimastigotes , 2006, Parasitology Research.

[19]  Nathan C Shaner,et al.  A guide to choosing fluorescent proteins , 2005, Nature Methods.

[20]  P. Desjeux.  Leishmaniasis: current situation and new perspectives. , 2004, Comparative immunology, microbiology and infectious diseases.

[21]  R. Spinelli,et al.  In vitro assays for evaluation of drug activity against Leishmania spp. , 2004, Research in microbiology.

[22]  A. Hehl,et al.  Expression of Green Fluorescent Protein as a Marker for Effects of Antileishmanial Compounds In Vitro , 2001, Antimicrobial Agents and Chemotherapy.

[23]  I. Wilson,et al.  Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity. , 2000, European journal of biochemistry.

[24]  R. Squatrito,et al.  Comparison of a novel redox dye cell growth assay to the ATP bioluminescence assay. , 1995, Gynecologic oncology.

[25]  张静,et al.  Banana Ovate family protein MaOFP1 and MADS-box protein MuMADS1 antagonistically regulated banana fruit ripening , 2015 .

[26]  D Steverding,et al.  A simple colorimetric method to screen drug cytotoxicity against Leishmania using the dye Alamar Blue. , 2000, Parasitology international.

[27]  R. Killick-Kendrick,et al.  Visceral leishmaniasis and post-kala-azar dermal leishmaniasis. , 1987 .